January 2004
Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
Dec   Feb

Channels
Children & Adolescents
Dual Diagnosis
Health Care Systems
Leadership
United States
United Kingdom
New Zealand & Australia

IIMHL UPDATE Home Page
User's Guide
Feature Articles Index

Links
IIMHL
SAMHSA (US)
NIMH (UK)
MOH(NZ)
MHCA


IIMHL Update is researched,
edited and designed
by Bill Davis.

For information about the International Initiative for Mental Health Leadership, please contact Fran Silvestri.











Webhealth
Webhealth has been specifically developed to provide access for people to connect with Health and Social Services. This web-based approach builds on the strengths of people and families to determine their support needs. Within the Webhealth website is Linkage. Linkage is a partnership between an NGO, Pathways; primary health care, Pinnacle; and a secondary provider/hospital, Health Waikato. It offers early intervention services with a “one stop shop” in central Hamilton and New Plymouth.



daily link  Tuesday, January 27, 2004


A Guide for Consumer Organization Leadership: Principles for Practice
Adobe Acrobat version of a report from the National Empowerment Center, made available at the Open Minds web site - " The purpose of this guidebook is to provide information about leading your organization toward that future. It summarizes those key leadership issues that are likely to be most relevant to the situations you face as consumer leaders. It provides information that will augment and enrich your current leadership practices and assist you in building new skills. The guide is broad-scoped, but with a premium on brevity. While it hopefully covers the more important leadership topics, it also leaves out others of necessity. Those we address, albeit briefly, contain references other resources where further information can be found...." See also the National Empowerment Center web site.  
comment []  permalink  


Mood Disorder Signaling Pathway Implicated in Schizophrenia
Reuters Health story at Medscape - "A signaling pathway linked to mood disorders may also play a role in schizophrenia, according to a report published in the January 25th online issue of Nature Genetics. Because it is a target for lithium, AKT1-GSK3beta signaling has been implicated in the pathogenesis of bipolar disorder. However, it was unclear if alterations in such pathways were also involved in other psychiatric disorders, including schizophrenia." "med"  
comment []  permalink  


Medscape Psychiatry Journal Scan, December 2003
"Journal Scan is the clinician's guide to the latest clinical research findings in the American Journal of Psychiatry, The Lancet, Archives of General Psychiatry, Journal of Clinical Psychiatry, and Journal of Clinical Psychopharmacology. Short summaries of feature articles include links to the article abstracts and full text, when available." [Viewing Medscape resources requires registration, which is free].  
comment []  permalink  


Medscape Journal Scan: Child and Adolescent Psychiatry, December 2003
Articles at Medscape from the American Journal of Psychiatry, the British Journal of Psychiatry, the Journal of the American Academy of Child and Adolescent Psychiatry and Psychiatric Services. [Viewing Medscape resources requires registration, which is free].  
comment []  permalink  


FDA Weighs Anti-Depressant Risk to Kids
AP story at PsycPORT - "Parents of children with depression must sort through an emotionally charged controversy in deciding on treatment: Do popular adult antidepressants sometimes increase the risk of suicide when they're given to kids? British authorities last month declared a list of common antidepressants unsuitable for children, citing that possibility. Next week, U.S. health authorities open public hearings on the issue, at which parents who blame the drugs for children's deaths are expected to face families who credit the same pills for saving lives."  
comment []  permalink  


Caution Urged on Anti-Psychotic Drugs
AP story reprinted at PsycPORT - "People taking certain drugs for schizophrenia, manic-depression, autism, dementia or several other psychiatric disorders should be carefully watched for signs they are developing diabetes, obesity or high cholesterol, four medical societies say. The recommendation follows recent studies that link those potential side effects to certain anti-psychotic drugs. The statement deals with six now available in the United States: Abilify, Clozaril, Geodon, Risperdal, Seroquel and Zyprexa. The recommendation, released Tuesday, comes from the American Diabetes Association, the American Psychiatric Association, the North American Association for the Study of Obesity, and the American Association of Clinical Endocrinologists. It appears in the February issue of the journal Diabetes Care."  
comment []  permalink  



Copyright 2003 © Bill Davis.

IIMHL Update is a project done in collaboration with MHCA and the Centre for Community Change International. IIMHL Update is powered by Radio Userland.